EPHB4 and cancer: Given the observed increase in Tregs with EphB4 knockdown in the cancer cell, we investigated whether CD4+ T cells within the TME differentiate into Tregs by treating CD4+ T cells with conditioned medium from MOC2 EphB4 knockdown cancer cells in vitro and conducting flow cytometry.